Involuntary body movements

Involuntary body movements is the spontaneous contraction or motion of muscles without deliberate intent.

As a drug effect it is acute and dose-proportional, easing as the substance wears off, which distinguishes it from movement disorders of neurological origin. It ranges from subtle twitches and mild tremor to pronounced muscle jerks, repetitive rocking, or rhythmic oscillation of the limbs.

It is an uncommon but well-documented effect across several drug classes. It is most commonly induced at moderate to high doses under psychedelics such as LSD, psilocybin mushrooms, and 1B-LSD, and under stimulants such as methamphetamine, 2-FA, and A-PHP; it also appears in a more disorganized form under deliriants such as diphenhydramine, datura, and amanita muscaria, and occasionally under depressants such as gabapentin and pregabalin.

Involuntary body movements are felt as a loss of muscular autonomy: the body acts of its own accord, producing twitches, tremors, or rhythmic motions that bypass conscious intention.

They commonly accompany a sense of physical restlessness — a driven, buzzing quality in the muscles — and can include jaw clenching, eye flickering, or spontaneous rocking of the torso. Attending to them tends to amplify rather than suppress them. At higher doses, particularly under stimulants and deliriants, the movements become coarser and more difficult to override.

Involuntary body movements arise through different pathways depending on the drug class:

• Psychedelics — act on 5-HT2A receptors, which modulate motor circuits; this typically produces rhythmic, exploratory movement that feels consonant with the broader experience.
• Stimulants — elevate dopamine and norepinephrine, increasing motor system excitability; at high doses this manifests as tremor, repetitive stereotyped movements, or muscle fasciculations.
• Deliriants — block muscarinic acetylcholine receptors, disrupting normal motor coordination and producing coarse, poorly regulated movement.
• Depressants — gabapentinoids modulate calcium channels and can produce muscle twitches and myoclonus, particularly at higher doses.

How much each pathway contributes in a given case is not fully understood.

Who experiences it, and how strongly, varies widely. Higher doses raise both its likelihood and intensity across all involved classes. Physical tension, fatigue, and concurrent anxiety tend to intensify it — especially under psychedelics and stimulants — as do prior conditions affecting muscle tone or nervous system sensitivity.

Expectation and attentional focus play a role too: people who notice and track the movements tend to experience them as more prominent. Staying physically relaxed and avoiding high doses are the most reliable factors that reduce it.